NYU Langone
A

Amyloidosis, Other Infiltrative Heart Disease, and What You Need to Know in 2023

By NYU Langone FEATURING Alex Reyentovich
By NYU Langone FEATURING Alex Reyentovich
523 views
December 28, 2023
1 Comment
Login to view comments. Click here to Login

Featured Video

27:06
Lilly Dermatology

Overview of Efficacy and Safety Data for a Biologic Therapy in Plaqu…

Feat. J. Peterson, J. Song

Featured Video

12:41
Lilly Dermatology

Long Term Efficacy and Safety Data Overview for a Plaque Psoriasis T…

Feat. M. Shahriari

Related Content

AUTOPLAY
10:05
Yale Cancer Center

Amyloidosis Background: Soft Tissue and GI/Liver AL Amyloid

Feat. S. Browning
15:38
CCM® Therapy

THT 2024: CCM® Therapy - Don’t Wait!

Feat. R. Kahwash
17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

53:31
CHEST 2022 Coverage

Approaching Sarcoidosis Therapy From a 21st Century Perspective

Feat. D. Culver
52:48
ZINCARE

Neurosarcoidosis: Clinical Manifestations, Diagnosis, Treatment

Feat. B. Stern
18:34
Houston Methodist DeBakey Heart and Vascular Center

ECG Interpretation: Everything You Need to Know to Understand and In…

Feat. A. Dave
16:45
SOHO 2022 Tenth Annual Meeting

SOHO 2022: Amyloidosis - Update and How To Use Novel Agents

Feat. S. Lentzsch
09:47
CCM® Therapy

THT 2024: Heart Failure Management Today – GDMT, CRT, and CCM® Thera…

Feat. J. Butler
28:18
UCLA Health

Advances and Updates in Sarcoidosis: Diagnosis and Treatment of Pulm…

Feat. J. Belperio
12:28
CCM® Therapy

THT 2024: Update on the Integra-D Trial - CCM® Therapy

Feat. N. Varma
47:24
Cleveland Clinic Taussig Cancer Institute

Diagnostic and Treatment Strategies for AL Amyloidosis in an Era of …

Feat. F. Anwer
24:54
Indy Hematology Review

Amyloidosis: Diagnosis, Risk Stratification, and Treatment

Feat. M. Gertz
54:48
CCM® Therapy

THT 2024: CCM® Therapy in Addition to GDMT: Optimizing Strategy fo…

Feat. R. Kahwash, N. Varma, J. Singh, N. Albert, J. Butler
30:27
Houston Methodist Hospital

Understanding AL Amyloidosis: Clinical Syndromes and Biological Impl…

Feat. V. Sanchorawala
59:18
CCM® Therapy

CCM® Around the World — How One Device-based Heart Failure Intervent…

Feat. K. Ellenbogen, J. Kuschyk, N. Varma, I. Whitman, J. Singh
27:05
American Society of Nuclear Cardiology

Interpreting a PYP Study for TTR Cardiac Amyloid

Feat. P. Soman, M. Harinstein, S. Divakaran
20:59
Mary E. Money

Digoxin Update 2023: Are the Current Digoxin Monitoring Guidelines H…

62:16
University of Louisville

Granulomatous Skin Diseases: Evaluation, Systemic Associations, and …

Feat. M. Rosenbach
37:36
Michigan Medicine

Implementation of Drug Therapies for Heart Failure with Reduced Ejec…

Feat. J. Golbus
16:48
Vaishnavi Kundel

ATS 2023 Insights: To PAP or Not to PAP - Heart Failure and Sleep Di…

Feat. V. Kundel